Shin-Ichiro Okamoto


Ontology type: schema:Person     


Person Info

NAME

Shin-Ichiro

SURNAME

Okamoto

Publications in SciGraph latest 50 shown

  • 2022-04-09 The safety and efficacy of hematopoietic stem cell mobilization using biosimilar filgrastim in related donors in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2022-02-11 Long-term follow-up of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab: post-marketing surveillance in Japan in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2021-10-03 Impact of chronic GVHD on QOL assessed by visual analogue scale in pediatric HSCT survivors and differences between raters: a cross-sectional observational study in Japan in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2021-08-06 Pre-conditioning intervention in patients with relapsed or refractory acute lymphoblastic leukemia who underwent allogeneic hematopoietic cell transplantation: a KSGCT multicenter retrospective analysis in ANNALS OF HEMATOLOGY
  • 2021-07-08 Successful ibrutinib treatment for central nervous system relapse of chronic lymphocytic leukemia after allogeneic hematopoietic stem cell transplantation in ANNALS OF HEMATOLOGY
  • 2021-05-11 Off-the-shelf bone marrow-derived mesenchymal stem cell treatment for acute graft-versus-host disease: real-world evidence in BONE MARROW TRANSPLANTATION
  • 2021-03-01 Phase 1 study of plerixafor in combination with total body irradiation-based myeloablative conditioning for allogeneic hematopoietic stem cell transplantation in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2021-01-08 Stopping tyrosine kinase inhibitors started after allogeneic HCT in patients with Philadelphia chromosome-positive leukemia in BONE MARROW TRANSPLANTATION
  • 2020-09-04 Pharmacokinetics of intravenous busulfan as condition for hematopoietic stem cell transplantation: comparison between combinations with cyclophosphamide and fludarabine in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2020-09-01 Use of unapproved or off-label drugs in Japan for the treatment of graft-versus-host disease and post-transplant viral infection in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2020-08-31 Results from multinational phase 3 studies of ravulizumab (ALXN1210) versus eculizumab in adults with paroxysmal nocturnal hemoglobinuria: subgroup analysis of Japanese patients in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2020-05-04 Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia conducted in Japan during the past quarter century in ANNALS OF HEMATOLOGY
  • 2020-03-14 Health-related quality of life in peripheral blood stem cell donors and bone marrow donors: a prospective study in Japan in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2020-03-12 In vivo expansion of functional human hematopoietic stem progenitor cells by butyzamide in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2020-03-09 Treatment outcomes of chronic-phase chronic myeloid leukemia with resistance and/or intolerance to a 1st-line tyrosine kinase inhibitor in Japan: the results of the New TARGET study 2nd-line in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2020-01-01 Treatment-free remission after first-line dasatinib treatment in patients with chronic myeloid leukemia in the chronic phase: the D-NewS Study of the Kanto CML Study Group in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2019-11-21 Clinical characteristics of human herpesvirus-6 myelitis after allogeneic hematopoietic stem cell transplantation and its favorable outcome by early intervention in BONE MARROW TRANSPLANTATION
  • 2019-11-19 Clinical practice recommendations for the diagnosis and management of human herpesvirus-6B encephalitis after allogeneic hematopoietic stem cell transplantation: the Japan Society for Hematopoietic Cell Transplantation in BONE MARROW TRANSPLANTATION
  • 2019-10-22 Impact of low-dose anti-thymocyte globulin on immune reconstitution after allogeneic hematopoietic cell transplantation in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2019-10-15 Correction: Worldwide Network for Blood and Marrow Transplantation (WBMT) perspective: the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countries in BONE MARROW TRANSPLANTATION
  • 2019-10-14 Autologous hematopoietic cell transplantation for acute myeloid leukemia in adults: 25 years of experience in Japan in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2019-09-19 Allogeneic hematopoietic cell transplantation in patients with untreated acute myeloid leukemia: a KSGCT multicenter retrospective analysis in BONE MARROW TRANSPLANTATION
  • 2019-09-04 Worldwide Network for Blood and Marrow Transplantation (WBMT) perspective: the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countries in BONE MARROW TRANSPLANTATION
  • 2019-07-05 Comparative study on baseline clinical characteristics of Asian versus non-Asian patients with paroxysmal nocturnal hemoglobinuria in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2019-06-11 Prognostic impact of cytogenetic abnormalities in adult patients with Philadelphia chromosome-negative ALL who underwent an allogeneic transplant in BONE MARROW TRANSPLANTATION
  • 2019-05-30 Prognostic index for patients with relapsed or refractory acute myeloid leukemia who underwent hematopoietic cell transplantation: a KSGCT multicenter analysis in LEUKEMIA
  • 2019-05-22 Efficacy and safety of oral deferasirox treatment for transfusional iron overload in pure red cell aplasia patients after allogeneic stem cell transplantation in ANNALS OF HEMATOLOGY
  • 2019-05-14 A consideration for efficient unrelated hematopoietic stem cell source acquisition—from an experience of Japan in BONE MARROW TRANSPLANTATION
  • 2019-05-14 Advances in hematopoietic stem cell transplantation in the Asia-Pacific region: the second report from APBMT 2005–2015 in BONE MARROW TRANSPLANTATION
  • 2019-02-18 “Worldwide Network for Blood & Marrow Transplantation (WBMT) special article, challenges facing emerging alternate donor registries” in BONE MARROW TRANSPLANTATION
  • 2019-02-14 Efficacy and safety of tyrosine kinase inhibitors for newly diagnosed chronic-phase chronic myeloid leukemia over a 5-year period: results from the Japanese registry obtained by the New TARGET system in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2019-01-24 Renal dysfunction and anemia associated with long-term imatinib treatment in patients with chronic myelogenous leukemia in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2018-10-04 Employment status was highly associated with quality of life after allogeneic hematopoietic cell transplantation, and the association may differ according to patient age and graft-versus-host disease status: analysis of a nationwide QOL survey in BONE MARROW TRANSPLANTATION
  • 2018-08-28 Factors affecting lower limb muscle strength and cardiopulmonary fitness after allogeneic hematopoietic stem cell transplantation in SUPPORTIVE CARE IN CANCER
  • 2018-08-18 A phase 3b, multicenter, open-label extension study of the long-term safety of anagrelide in Japanese adults with essential thrombocythemia in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2018-07-06 Correction to: Effects of eculizumab treatment on quality of life in patients with paroxysmal nocturnal hemoglobinuria in Japan in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2018-06-29 Extracorporeal photopheresis with TC-V in Japanese patients with steroid-resistant chronic graft-versus-host disease in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2018-06-15 Availability of HLA-allele-matched unrelated donors: estimation from haplotype frequency in the Japanese population in BONE MARROW TRANSPLANTATION
  • 2018-04 Daratumumab, lenalidomide, and dexamethasone in East Asian patients with relapsed or refractory multiple myeloma: subgroup analyses of the phase 3 POLLUX study in BLOOD CANCER JOURNAL
  • 2018-01-30 Effects of eculizumab treatment on quality of life in patients with paroxysmal nocturnal hemoglobinuria in Japan in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2018-01-24 The Japan Marrow Donor Program, 25 years of experience in achieving 20,000 bone marrow transplantations: organization structure, activity, and financial basis in BONE MARROW TRANSPLANTATION
  • 2018-01-05 Deferasirox for the treatment of iron overload after allogeneic hematopoietic cell transplantation: multicenter phase I study (KSGCT1302) in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2017-10-13 Prospective observational study on the first 51 cases of peripheral blood stem cell transplantation from unrelated donors in Japan in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2017-10-09 Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography with gallium-67 scintigraphy in the initial clinical staging of diffuse large B-cell lymphoma in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2017-10-06 Evaluation of the dose and efficacy of ruxolitinib in Japanese patients with myelofibrosis in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2017-09-27 Ruxolitinib is effective and safe in Japanese patients with hydroxyurea-resistant or hydroxyurea-intolerant polycythemia vera with splenomegaly in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2017-09-07 Clinical and radiological characteristics of patients with late-onset severe restrictive lung defect after hematopoietic stem cell transplantation in BMC PULMONARY MEDICINE
  • 2017-09-06 In Vivo Confocal Microscopy Evaluation of Ocular Surface with Graft-Versus-Host Disease-Related Dry Eye Disease in SCIENTIFIC REPORTS
  • 2017-07-07 Transfusion in ESTABLISHING A HEMATOPOIETIC STEM CELL TRANSPLANTATION UNIT
  • 2017-05-17 Effects of calcineurin inhibitors on sodium excretion in recipients of allogeneic hematopoietic stem cell transplantation in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "http://www.grid.ac/institutes/grid.26091.3c", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.26999.3d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.39158.36", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.256115.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.189967.8", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.272242.3", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411321.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.415107.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412781.9", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.470100.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.265070.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.272264.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.265073.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.265050.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.270560.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411873.8", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412096.8", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.63906.3a", 
            "type": "Organization"
          }
        ], 
        "familyName": "Okamoto", 
        "givenName": "Shin-Ichiro", 
        "id": "sg:person.0715264147.87", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0715264147.87"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2022-06-01T22:53", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220601/entities/gbq_results/person/person_860.jsonl", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.0715264147.87'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.0715264147.87'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.0715264147.87'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.0715264147.87'


     

    This table displays all metadata directly associated to this object as RDF triples.

    50 TRIPLES      10 PREDICATES      28 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.0715264147.87 schema:affiliation Nedb17aa4b0df426ca538bb8e80ae6e92
    2 grid-institutes:grid.189967.8
    3 grid-institutes:grid.256115.4
    4 grid-institutes:grid.265050.4
    5 grid-institutes:grid.265070.6
    6 grid-institutes:grid.265073.5
    7 grid-institutes:grid.26999.3d
    8 grid-institutes:grid.270560.6
    9 grid-institutes:grid.272242.3
    10 grid-institutes:grid.272264.7
    11 grid-institutes:grid.39158.36
    12 grid-institutes:grid.411321.4
    13 grid-institutes:grid.411873.8
    14 grid-institutes:grid.412096.8
    15 grid-institutes:grid.412781.9
    16 grid-institutes:grid.415107.6
    17 grid-institutes:grid.470100.2
    18 grid-institutes:grid.63906.3a
    19 schema:familyName Okamoto
    20 schema:givenName Shin-Ichiro
    21 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0715264147.87
    22 schema:sdDatePublished 2022-06-01T22:53
    23 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    24 schema:sdPublisher Nd7a133434e4146eeac2efc3cb88914df
    25 sgo:license sg:explorer/license/
    26 sgo:sdDataset persons
    27 rdf:type schema:Person
    28 Nd7a133434e4146eeac2efc3cb88914df schema:name Springer Nature - SN SciGraph project
    29 rdf:type schema:Organization
    30 Nedb17aa4b0df426ca538bb8e80ae6e92 schema:affiliation grid-institutes:grid.26091.3c
    31 sgo:isCurrent true
    32 rdf:type schema:OrganizationRole
    33 grid-institutes:grid.189967.8 schema:Organization
    34 grid-institutes:grid.256115.4 schema:Organization
    35 grid-institutes:grid.26091.3c schema:Organization
    36 grid-institutes:grid.265050.4 schema:Organization
    37 grid-institutes:grid.265070.6 schema:Organization
    38 grid-institutes:grid.265073.5 schema:Organization
    39 grid-institutes:grid.26999.3d schema:Organization
    40 grid-institutes:grid.270560.6 schema:Organization
    41 grid-institutes:grid.272242.3 schema:Organization
    42 grid-institutes:grid.272264.7 schema:Organization
    43 grid-institutes:grid.39158.36 schema:Organization
    44 grid-institutes:grid.411321.4 schema:Organization
    45 grid-institutes:grid.411873.8 schema:Organization
    46 grid-institutes:grid.412096.8 schema:Organization
    47 grid-institutes:grid.412781.9 schema:Organization
    48 grid-institutes:grid.415107.6 schema:Organization
    49 grid-institutes:grid.470100.2 schema:Organization
    50 grid-institutes:grid.63906.3a schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...